申请人:Freskos N. John
公开号:US20050101641A1
公开(公告)日:2005-05-12
This invention is directed to aromatic sulfone hydroxamic acids (including hydroxamates) and salts thereof that, inter alia, inhibit matrix metalloproteinase (also known as “matrix metalloprotease” or “MMP”) activity and/or aggrecanase activity. This invention also is directed to a prevention or treatment method that comprises administering such a compound or salt in an MMP-inhibiting and/or aggrecanase-inhibiting effective amount to an animal, particularly a mammal having (or disposed to having) a pathological condition associated with MMP and/or aggrecanase activity.
该发明涉及芳香磺酰羟肟酸(包括羟肟酸盐)及其盐,其可以抑制基质金属蛋白酶(也称为“基质金属蛋白酶”或“MMP”)活性和/或聚集素酶活性。该发明还涉及一种预防或治疗方法,包括向动物,特别是患有(或倾向于患有)与MMP和/或聚集素酶活性相关的病理状况的哺乳动物中,以MMP抑制和/或聚集素酶抑制有效剂量的该化合物或盐的给药。